Commentary · 21 Feb 2026
Conference abstractPublished 10 Sep 2012
Prolylcarboxypeptidase may contributes to the disease process of prostate cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Prolylcarboxypeptidase (PRCP) metabolizes angiotensin II (Ang II, a pressor agent), angiotensin III (Ang III, a vasoactive peptide), and des-Arg9-bradykinin (BK1-8, a known proinflammatory mediator). Prostate-cell growth involves two subtypes of bradykinin (BK) receptors, B1 and B2. It is also known that kinin receptor-mediated intracellular signaling plays an important role in promoting cell growth, migration, and invasion. B1 is a cell membrane receptor for des-Arg 9 -BK and des-Arg 10 - kallidin, an interaction well-known to activate inflammation. Upregulation of B1 is observed in patients with cancer. B1 expression is significantly higher than B2 in the tissue with cancer cells. It has been proposed that the B1 receptor is upregulated by its own agonists (Des-Arg 9 -BK, des-Arg 10 -kallidin). An alternative interpretation is that this adaptation can be attributed to the downregulation of PRCP. PRCP-dependent metabolism of angiotensin(s) ? and BK1-8 signaling pathway might be involved in the pathogenesis of BPH. We hypothesized that molecular targeting of PRCP-dependent pathways can prevent prostate inflammation and subsequent cancer development. Our findings provide the first evidence that PRCP expression and activity are compromised in cultured prostate cancer cells
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Zia Shariat-Madar”
